Published in N Engl J Med on April 27, 1978
Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev (1989) 16.53
Shiga and Shiga-like toxins. Microbiol Rev (1987) 8.58
Genetic basis of virulence in Shigella species. Microbiol Rev (1991) 4.94
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun (1986) 2.64
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun (1988) 2.12
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun (1991) 2.01
Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut (1993) 1.98
Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1. Infect Immun (1988) 1.94
Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev (1995) 1.73
Causes of the haemolytic uraemic syndrome. BMJ (1989) 1.66
Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun (1994) 1.61
Haemolytic uraemic syndrome. Arch Dis Child (1984) 1.41
Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun (1992) 1.38
Radioimmunoassay for Gram-negative bacterial lipopolysaccharide O antigens: influence of antigen solubility. Infect Immun (1979) 1.29
An evaluation of treatment with heparin in the haemolytic-uraemic syndrome successfully treated by peritoneal dialysis. Arch Dis Child (1980) 1.24
Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infect Immun (2004) 1.19
Escherichia coli diarrhoea. J Hyg (Lond) (1985) 1.16
Ultrastructural pathology of the rectal mucosa in Shigella dysentery. Am J Pathol (1986) 1.15
Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol (2013) 1.13
Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs. Can J Vet Res (1989) 1.09
Study of circulating immune complex size in systemic lupus erythematosus. Clin Exp Immunol (1981) 1.08
Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun (1998) 1.06
Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic. PLoS One (2013) 1.04
Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology? Ann Rheum Dis (1984) 1.02
Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. J Clin Microbiol (1992) 1.01
Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland. Am J Public Health (1988) 0.99
Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid. Infect Immun (1998) 0.99
An animal model of haemolytic--uraemic syndrome in shigellosis: lipopolysaccharides of Shigella dysenteriae I and S. flexneri produce leucocyte-mediated renal cortical necrosis in rabbits. Br J Exp Pathol (1985) 0.98
Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children. Arch Dis Child (1991) 0.96
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun (2005) 0.96
Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease. J Health Popul Nutr (2012) 0.93
Activation of glomerular mesangial cells by gram-negative bacterial cell wall components. Am J Pathol (1988) 0.92
Hemolytic-uremic syndrome--an outbreak in Sacramento, California. West J Med (1986) 0.91
Cholestatic jaundice in the haemolytic-uraemic syndrome: a case report. Gut (1985) 0.91
Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol (1999) 0.89
Shigella: A Highly Virulent and Elusive Pathogen. Curr Trop Med Rep (2014) 0.88
Shigellemia. West J Med (1984) 0.87
Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome. Clin Diagn Lab Immunol (1999) 0.87
Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1. Infect Immun (2010) 0.86
Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol (2008) 0.85
Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB. Infect Immun (1997) 0.85
New insights into the haemolytic uraemic syndromes. Arch Dis Child (1990) 0.83
In vitro prostacyclin production in the hemolytic-uremic syndrome. West J Med (1986) 0.83
Advances in haemolytic uraemic syndrome. Arch Dis Child (1998) 0.83
Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One (2011) 0.81
p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells. Infect Immun (2007) 0.81
Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDS. J Clin Microbiol (1991) 0.81
Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome. Pediatr Nephrol (2004) 0.79
Haemolytic-uraemic syndrome presenting as an acute abdomen. Postgrad Med J (1987) 0.79
Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice. Clin Vaccine Immunol (2015) 0.77
Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex. PLoS One (2013) 0.77
British Paediatric Association-Communicable Disease Surveillance Centre surveillance of haemolytic uraemic syndrome 1983-4. Br Med J (Clin Res Ed) (1986) 0.75
Shigellosis: analysis of 176 isolations. J Natl Med Assoc (1979) 0.75
Thrombotic thrombocytopenic purpura associated with pneumococcal sepsis. Can J Infect Dis (1993) 0.75
Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1. Antimicrob Agents Chemother (1980) 0.75
An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet (1995) 13.84
The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr (1967) 10.30
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84
Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ (2008) 7.63
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet (1988) 7.00
Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (1995) 6.84
Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science (1972) 6.80
Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab Clin Med (1970) 6.04
Microstructural maturation of the human brain from childhood to adulthood. Neuroimage (2008) 5.30
RECONSTITUTION OF ACTIVE TOBACCO MOSAIC VIRUS FROM ITS INACTIVE PROTEIN AND NUCLEIC ACID COMPONENTS. Proc Natl Acad Sci U S A (1955) 5.25
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science (1996) 5.08
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85
Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics (1992) 4.78
Cyclospora species--a new protozoan pathogen of humans. N Engl J Med (1993) 4.56
Differences in anti-protein A activity among IgG subgroups. J Immunol (1969) 4.56
Identification of an SCF ubiquitin-ligase complex required for auxin response in Arabidopsis thaliana. Genes Dev (1999) 4.35
Clottable protein in Limulus; its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh (1968) 3.90
Phylogenetic insight into evolution of mammalian Fc fragment of gamma G globulin using staphylococcal protein A. J Immunol (1970) 3.84
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis (2008) 3.77
Microtubules from mammalian brain: some properties of their depolymerization products and a proposed mechanism of assembly and disassembly. Proc Natl Acad Sci U S A (1974) 3.59
Detection of endotoxin in the blood of patients with sepsis due to gran-negative bacteria. N Engl J Med (1970) 3.55
Community infection ratio as an indicator for tuberculosis control. Lancet (1995) 3.53
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Preparation of tubulin from brain. Methods Enzymol (1982) 3.39
Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med (1977) 3.38
Opsonic, agglutinating, and complement-fixing antibodies in patients with subacute bacterial endocarditis. J Lab Clin Med (1968) 3.20
Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) (1977) 3.20
Effect of El Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children. Lancet (2000) 3.11
Factors associated with HIV sero-status in young rural South African women: connections between intimate partner violence and HIV. Int J Epidemiol (2006) 3.07
Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg (1978) 3.06
ELECTRON SHADOW MICROGRAPHY OF THE TOBACCO MOSAIC VIRUS PROTEIN. Science (1945) 3.00
Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98
Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest (1973) 2.84
Failure of the International Normalized Ratio to generate consistent results within a local medical community. Am J Clin Pathol (1993) 2.81
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med (1976) 2.77
Inhibition of streptococcal attachment to receptors on human buccal epithelial cells by antigenically similar salivary glycoproteins. Infect Immun (1975) 2.76
Cyanobacterial phycobilisomes. Characterization of the phycobilisomes of Synechococcus sp. 6301. J Biol Chem (1978) 2.73
Separation and characterization of microtubule proteins from calf brain. Biochemistry (1977) 2.71
Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev (2001) 2.69
Site-specific DNA condensation and pairing mediated by the int protein of bacteriophage lambda. Proc Natl Acad Sci U S A (1982) 2.67
Use of polylysine for adsorption of nuclei acids and enzymes to electron microscope specimen films. Proc Natl Acad Sci U S A (1977) 2.67
Diarrhoeal mortality in two Bangladeshi villages with and without community-based oral rehydration therapy. Lancet (1979) 2.66
A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Trop Med Int Health (2006) 2.64
Killing of Mycobacterium microti by immunologically activated macrophages. Nature (1981) 2.62
An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest (1972) 2.61
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology (1997) 2.60
Antiphagocytic effects of staphylococcal protein A. J Immunol (1969) 2.59
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57
Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg (1998) 2.49
Pathologic findings in mesangiopathic glomerulonephritis in Navajo Indians. Arch Pathol Lab Med (1989) 2.48
A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective cesarean section. Anesthesiology (1993) 2.44
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum (1973) 2.40
Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins. J Immunol (1970) 2.38
Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart (2004) 2.38
Understanding men's health and illness: a gender-relations approach to policy, research, and practice. J Am Coll Health (2000) 2.34
Electron microscopy of tobacco mosaic virus under conditions of minimal beam exposure. J Mol Biol (1970) 2.32
Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet (1987) 2.32
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol (1986) 2.31
Mode of DNA packing within bacteriophage heads. J Mol Biol (1973) 2.29
Molecular assays for surveillance of antifolate-resistant malaria. Lancet (1998) 2.26
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest (1973) 2.19
Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of protein A residues on bacteria. J Immunol (1970) 2.19
Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol (1998) 2.17
Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart (2009) 2.16
An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J Infect Dis (1975) 2.15
Opsonic activity of agammaglobulinemic human sera. J Immunol (1971) 2.13
GM allotypes in Native Americans: evidence for three distinct migrations across the Bering land bridge. Am J Phys Anthropol (1985) 2.11
The mechanism of microtubule assembly in vitro. J Supramol Struct (1974) 2.10
Prevalence of emotional, physical and sexual abuse of women in three South African provinces. S Afr Med J (2001) 2.09
Quantitative comparison of in vitro and in vivo methods for the detection of endotoxin. J Lab Clin Med (1971) 2.08
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr (1999) 2.05
Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol (1991) 2.04
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
A critical reappraisal of the bleeding time. Semin Thromb Hemost (1990) 2.03
Periodontal disease at the biofilm-gingival interface. J Periodontol (2007) 2.01
Rheumatoid factors in subacute bacterial endocarditis--bacterium, duration of disease or genetic predisposition? Ann Intern Med (1968) 2.00
T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol (1974) 1.98
Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology (1974) 1.97
The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96
Validity of the 'Ten Questions' for screening serious childhood disability: results from urban Bangladesh. Int J Epidemiol (1990) 1.95
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Suxamethonium in bunged cannulae. Anaesth Intensive Care (1991) 1.94
Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res (1986) 1.94
Microtubules grow and shorten at intrinsically variable rates. J Biol Chem (1992) 1.92
Molecular architecture of a light-harvesting antenna. In vitro assembly of the rod substructures of Synechococcus 6301 phycobilisomes. J Biol Chem (1981) 1.92
Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res (1992) 1.92
Factors associated with HIV sero-positivity in young, rural South African men. Int J Epidemiol (2006) 1.90
Fecal contamination of shanty town toddlers in households with non-corralled poultry, Lima, Peru. Am J Public Health (1990) 1.89
Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88